Biotech & Health

Eko Health scores $41M to detect heart disease earlier and more accurately

Biotech & Health /

In 1816, French physician René Laennec invented an instrument that allowed doctors to listen to human hearts and lungs. That device — a stethoscope — eventually evolved from a simple wooden tube to a lightweight two-earpiece version most doctors today wear on their necks. Eko Health, a startup founded in 2013, is bringing this ubiquitous […]

Eko Health scores $41M to detect heart disease earlier and more accurately Read More »

Sword Health raises $130 million and its valuation soars to $3 billion

Biotech & Health /

Sword Health, an AI-powered virtual physical therapy startup, has raised $30 million and let employees sell $100 million worth of equity to new and existing investors, including Khosla Ventures. The round brings the nine-year-old company’s valuation to $3 billion, a 50% increase from the $2 billion value it garnered in its Series D in November 2021. The

Sword Health raises $130 million and its valuation soars to $3 billion Read More »

General Catalyst-backed Jasper Health lays off staff

Biotech & Health /

Jasper Health, a cancer care platform startup, laid off a substantial part of its workforce, TechCrunch has learned. Engineering and product design were among the departments impacted by the cuts, according to posts on LinkedIn from impacted employees. TechCrunch was unable to independently verify the exact number of people who were cut, but an industry

General Catalyst-backed Jasper Health lays off staff Read More »

Billionaire Groupon founder Eric Lefkofsky is back with another IPO: AI health tech Tempus

Biotech & Health /

Eric Lefkofsky knows the public listing rodeo well and is about to enter it for a fourth time. The serial entrepreneur, whose net worth is estimated at nearly $4 billion, has already taken three businesses he’s founded public.  Today he’s the founder of Tempus, a genomic testing and data analysis company preparing to IPO. But

Billionaire Groupon founder Eric Lefkofsky is back with another IPO: AI health tech Tempus Read More »

Valar Labs debuts AI-powered cancer care prediction tool and secures $22M

Biotech & Health /

Putting AI to work in the healthcare industry is a tricky business; it’s even more so in oncology, where the stakes are especially high. Biotech startup Valar Labs is aiming high but starting small with a tool that accurately predicts certain treatment outcomes, potentially saving precious time for patients. It has raised $22 million to

Valar Labs debuts AI-powered cancer care prediction tool and secures $22M Read More »

Mental health insurance platform ifeel raises a $20 million Series B

Biotech & Health /

Mental health issues like stress, depression and anxiety can lead to work-related illnesses, absences and long-term sick leave. But many companies think offering a gym membership is enough. Ifeel — a European startup that decided mental health should be tackled differently and which raised $6.6 million in 2021 — has now raised a $20 million

Mental health insurance platform ifeel raises a $20 million Series B Read More »

US pharma giant Cencora says Americans’ health information stolen in data breach

Biotech & Health /

U.S. pharmaceutical giant Cencora says it is notifying affected individuals that their personal and highly sensitive medical information was stolen during a cyberattack and data breach earlier this year.  In letters to affected individuals sent out this week, Cencora said that the data from its systems includes patient names, their postal address and date of

US pharma giant Cencora says Americans’ health information stolen in data breach Read More »

IndieBio’s SF incubator lineup is making some wild biotech promises

Biotech & Health /

IndieBio’s Bay Area incubator is about to debut its 15th cohort of biotech startups. We took special note of a few, which were making some major, bordering on ludicrous, claims that could pay off in a big way. Biotech has been creeping out in recent years to touch adjacent industries, as companies find how much

IndieBio’s SF incubator lineup is making some wild biotech promises Read More »